Another Bust for Alzheimer's Drugs
• Susan Young via TechnologyReview.comAlthough Eli Lilly's anti-amyloid compound fails to slow decline in two large trials, patients with mild forms of the disease show some benefit
Although Eli Lilly's anti-amyloid compound fails to slow decline in two large trials, patients with mild forms of the disease show some benefit